Literature DB >> 30184197

Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls.

Ellenor Mittendorfer-Rutz1, Syed Rahman1, Antti Tanskanen1,2,3, Maila Majak4, Juha Mehtälä4, Fabian Hoti4, Erik Jedenius5, Dana Enkusson5, Amy Leval6, Jan Sermon7, Heidi Taipale1,8, Jari Tiihonen1,2.   

Abstract

BACKGROUND: The study aimed to (1) compare the risk of health care use, adverse health status, and work productivity loss of parents of patients with schizophrenia to parents of patients with multiple sclerosis (MS), rheumatoid arthritis (RA), epilepsy, and healthy controls; and (2) evaluate such outcome measures while considering disease severity of schizophrenia.
METHODS: Based on linkage of Swedish registers, at least one parent was included (n = 18215) of patients with schizophrenia (information 2006-2013, n = 10883). Similarly, parental information was linked to patients with MS, RA, epilepsy, and matched healthy controls, comprising 11292, 15516, 34715, and 18408 parents, respectively. Disease severity of schizophrenia was analyzed. Different regression models yielding odds ratios (OR), hazard ratios (HR), or relative risks (RR) with 95% confidence intervals (CI) were run.
RESULTS: Psychiatric health care use, mainly due to anxiety and affective disorders, showed a strongly increasing trend for parents of patients with schizophrenia throughout the observation period. During the follow-up, these parents had an up to 2.7 times higher risk of specialized psychiatric health care and receipt of social welfare benefits than other parents. Parents of the moderately severely ill patients with schizophrenia had higher risk estimates for psychiatric health care (RR: 1.12; 95% CI: 1.07-1.17) compared with parents of least severely ill patients.
CONCLUSIONS: Parents of patients with schizophrenia have a considerably higher risk of psychiatric health care and social welfare benefit receipt than other parents. Psychiatric health care use worsens over time and with increasing disease severity of the offspring.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  caregiver burden; schizophrenia; sickness absence; work productivity

Year:  2019        PMID: 30184197      PMCID: PMC6581137          DOI: 10.1093/schbul/sby130

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  59 in total

1.  Caregiver burden in recent-onset schizophrenia and spectrum disorders: the influence of symptoms and personality traits.

Authors:  Jiska E D Wolthaus; Peter M A J Dingemans; Aart H Schene; Donald H Linszen; Durk Wiersma; Robbert J Van Den Bosch; Wiepke Cahn; Ron Hijman
Journal:  J Nerv Ment Dis       Date:  2002-04       Impact factor: 2.254

Review 2.  Recent advances in nanomedicines for the treatment of rheumatoid arthritis.

Authors:  Qin Wang; Xun Sun
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 3.  Psychiatry in transition: outcomes of mental health policy shift in Italy.

Authors:  A Barbato
Journal:  Aust N Z J Psychiatry       Date:  1998-10       Impact factor: 5.744

Review 4.  Multiple sclerosis-a quiet revolution.

Authors:  Richard M Ransohoff; David A Hafler; Claudia F Lucchinetti
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

5.  'We didn't have a clue': Family caregivers' experiences of the communication of a diagnosis of schizophrenia.

Authors:  Sue Outram; Gillian Harris; Brian Kelly; Carma L Bylund; Martin Cohen; Yulia Landa; Tomer Levin; Harsimrat Sandhu; Marina Vamos; Carmel Loughland
Journal:  Int J Soc Psychiatry       Date:  2014-05-27

6.  Primary caregivers of schizophrenia outpatients: burden and predictor variables.

Authors:  Pamela Grandón; Cristina Jenaro; Serafín Lemos
Journal:  Psychiatry Res       Date:  2008-02-20       Impact factor: 3.222

Review 7.  Outcomes of public concern in schizophrenia.

Authors:  Iain Kooyman; Kimberlie Dean; Samuel Harvey; Elizabeth Walsh
Journal:  Br J Psychiatry Suppl       Date:  2007-08

8.  "Sometimes It's Difficult to Have a Normal Life": Results from a Qualitative Study Exploring Caregiver Burden in Schizophrenia.

Authors:  Adam Gater; Diana Rofail; Chloe Tolley; Chris Marshall; Linda Abetz-Webb; Steven H Zarit; Carmen Galani Berardo
Journal:  Schizophr Res Treatment       Date:  2014-04-03

9.  Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5.

Authors:  Shaloo Gupta; Gina Isherwood; Kevin Jones; Kristel Van Impe
Journal:  Clinicoecon Outcomes Res       Date:  2015-11-25

Review 10.  Schizophrenia.

Authors:  Michael J Owen; Akira Sawa; Preben B Mortensen
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

View more
  9 in total

1.  Societal Costs of Schizophrenia in Denmark: A Nationwide Matched Controlled Study of Patients and Spouses Before and After Initial Diagnosis.

Authors:  Lene Halling Hastrup; Erik Simonsen; Rikke Ibsen; Jacob Kjellberg; Poul Jennum
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

2.  COVID-19 lockdown - who cares? The first lockdown from the perspective of relatives of people with severe mental illness.

Authors:  Erlend Mork; Sofie R Aminoff; Elizabeth Ann Barrett; Carmen Simonsen; Wenche Ten Velden Hegelstad; Trine Vik Lagerberg; Ingrid Melle; Kristin Lie Romm
Journal:  BMC Public Health       Date:  2022-06-02       Impact factor: 4.135

3.  Areas of Interest and Stigmatic Attitudes of the General Public in Five Relevant Medical Conditions: Thematic and Quantitative Analysis Using Twitter.

Authors:  Miguel Angel Alvarez-Mon; María Llavero-Valero; Angel Asunsolo Del Barco; Melchor Alvarez-Mon; Rodrigo Sánchez-Bayona; Victor Pereira-Sanchez; Maria Vallejo-Valdivielso; Jorge Monserrat; Guillermo Lahera
Journal:  J Med Internet Res       Date:  2019-05-28       Impact factor: 5.428

4.  Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring.

Authors:  Heidi Taipale; Syed Rahman; Antti Tanskanen; Juha Mehtälä; Fabian Hoti; Erik Jedenius; Dana Enkusson; Amy Leval; Jan Sermon; Jari Tiihonen; Ellenor Mittendorfer-Rutz
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

5.  Family caregiving and chronic illness management in schizophrenia: positive and negative aspects of caregiving.

Authors:  Man-Man Peng; Zhiying Ma; Mao-Sheng Ran
Journal:  BMC Psychol       Date:  2022-03-31

6.  Assessing the impact of caregiving on informal caregivers of adults with a mental disorder in OECD countries: A systematic literature review of concepts and their respective questionnaires.

Authors:  Leonarda G M Bremmers; Isabelle N Fabbricotti; Eleonora S Gräler; Carin A Uyl-de Groot; Leona Hakkaart-van Roijen
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

7.  Caregiving-related experiences associated with depression severity and its symptomatology among caregivers of individuals with a severe mental disorder: an online cross-sectional study.

Authors:  Louis-Ferdinand Lespine; Anne-Lise Bohec; Jean-Michel Dorey; Céline Dubien Berbey; Charles Lourioux; Thierry D'amato; Marie-Odile Krebs; Isabelle Rouch; Romain Rey
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-30       Impact factor: 5.760

8.  The genetic basis for the inverse relationship between rheumatoid arthritis and schizophrenia.

Authors:  Mansour Zamanpoor; Hamid Ghaedi; Mir Davood Omrani
Journal:  Mol Genet Genomic Med       Date:  2020-09-23       Impact factor: 2.183

9.  Understanding the Economic Value and Impacts on Informal Carers of People Living with Mental Health Conditions.

Authors:  David McDaid; A-La Park
Journal:  Int J Environ Res Public Health       Date:  2022-03-01       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.